Stephens Inc. AR Buys Shares of 5,345 Tempus AI, Inc. $TEM

Stephens Inc. AR purchased a new position in shares of Tempus AI, Inc. (NASDAQ:TEM) during the second quarter, Holdings Channel.com reports. The fund purchased 5,345 shares of the company’s stock, valued at approximately $340,000.

Other large investors have also modified their holdings of the company. Pathway Capital Management LP purchased a new stake in shares of Tempus AI during the first quarter valued at $8,576,000. Sumitomo Mitsui Trust Group Inc. grew its holdings in shares of Tempus AI by 31.4% during the first quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,255,477 shares of the company’s stock valued at $205,284,000 after buying an additional 1,016,384 shares during the last quarter. Massachusetts Financial Services Co. MA grew its holdings in shares of Tempus AI by 92.6% during the first quarter. Massachusetts Financial Services Co. MA now owns 578,890 shares of the company’s stock valued at $27,926,000 after buying an additional 278,311 shares during the last quarter. Cambridge Investment Research Advisors Inc. purchased a new stake in shares of Tempus AI during the first quarter valued at $1,019,000. Finally, ARK Investment Management LLC grew its holdings in shares of Tempus AI by 35.9% during the first quarter. ARK Investment Management LLC now owns 7,501,399 shares of the company’s stock valued at $361,867,000 after buying an additional 1,981,755 shares during the last quarter. Hedge funds and other institutional investors own 24.22% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the stock. BTIG Research boosted their price objective on shares of Tempus AI from $85.00 to $96.00 and gave the company a “buy” rating in a report on Wednesday, October 22nd. Weiss Ratings reiterated a “sell (d-)” rating on shares of Tempus AI in a research report on Saturday. Piper Sandler upped their target price on Tempus AI from $70.00 to $105.00 and gave the company a “neutral” rating in a research report on Wednesday. TD Cowen lowered Tempus AI from a “buy” rating to a “hold” rating and set a $88.00 target price on the stock. in a research report on Tuesday, October 21st. Finally, Guggenheim upped their target price on Tempus AI from $80.00 to $95.00 and gave the company a “buy” rating in a research report on Friday, September 26th. Seven research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Tempus AI currently has an average rating of “Hold” and a consensus target price of $79.38.

Insiders Place Their Bets

In other Tempus AI news, CEO Eric P. Lefkofsky sold 332,500 shares of the company’s stock in a transaction dated Thursday, September 25th. The shares were sold at an average price of $76.56, for a total value of $25,456,200.00. Following the completion of the transaction, the chief executive officer owned 9,141,032 shares in the company, valued at approximately $699,837,409.92. This represents a 3.51% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Erik Phelps sold 3,664 shares of the company’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total transaction of $273,517.60. Following the completion of the transaction, the executive vice president owned 94,115 shares of the company’s stock, valued at approximately $7,025,684.75. This trade represents a 3.75% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 767,412 shares of company stock worth $57,618,856. Corporate insiders own 26.27% of the company’s stock.

Tempus AI Price Performance

Shares of NASDAQ TEM opened at $89.23 on Monday. The business’s 50 day moving average price is $84.20 and its 200 day moving average price is $68.05. The firm has a market cap of $15.50 billion, a P/E ratio of -74.98 and a beta of 4.87. Tempus AI, Inc. has a 52 week low of $31.36 and a 52 week high of $104.32. The company has a quick ratio of 1.43, a current ratio of 1.54 and a debt-to-equity ratio of 2.58.

Tempus AI (NASDAQ:TEM) last released its quarterly earnings data on Friday, August 8th. The company reported ($0.22) EPS for the quarter, topping the consensus estimate of ($0.23) by $0.01. Tempus AI had a negative return on equity of 122.86% and a negative net margin of 20.98%.The business had revenue of $314.64 million for the quarter, compared to analyst estimates of $296.84 million. During the same quarter in the prior year, the firm posted ($6.86) EPS. The business’s quarterly revenue was up 89.5% compared to the same quarter last year. Tempus AI has set its FY 2025 guidance at EPS. On average, sell-side analysts expect that Tempus AI, Inc. will post -6.15 earnings per share for the current year.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.